Burbaeva G Sh, Boksha I S, Tereshkina E B, Savushkina O K, Prokhorova T A, Vorobyeva E A
Mental Health Research Center, Russian Academy of Medical Sciences, 34, Kashirskoye Shosse, Moscow, Russia, 115522.
Cerebellum. 2014 Oct;13(5):607-15. doi: 10.1007/s12311-014-0573-4.
Enzymes of glutamate and GABA metabolism in postmortem cerebellum from patients with Alzheimer's disease (AD) have not been comprehensively studied. The present work reports results of original comparative study on levels of phosphate-activated glutaminase (PAG) and glutamic acid decarboxylase isoenzymes (GAD65/67) in autopsied cerebellum samples from AD patients and matched controls (13 cases in each group) as well as summarizes published evidence for altered levels of PAG and GAD65/67 in AD brain. Altered (decreased) levels of these enzymes and changes in links between amounts of these enzymes and other glutamate-metabolizing enzymes (such as glutamate dehydrogenase and glutamine synthetase-like protein) in AD cerebella suggest significantly impaired glutamate and GABA metabolism in this brain region, which was previously regarded as not substantially involved in AD pathogenesis.
阿尔茨海默病(AD)患者死后小脑谷氨酸和γ-氨基丁酸(GABA)代谢的酶尚未得到全面研究。本研究报告了对AD患者和匹配对照(每组13例)尸检小脑样本中磷酸激活谷氨酰胺酶(PAG)和谷氨酸脱羧酶同工酶(GAD65/67)水平进行的原始比较研究结果,并总结了已发表的关于AD脑内PAG和GAD65/67水平改变的证据。AD小脑内这些酶水平的改变(降低)以及这些酶与其他谷氨酸代谢酶(如谷氨酸脱氢酶和谷氨酰胺合成酶样蛋白)数量之间联系的变化表明,该脑区的谷氨酸和GABA代谢显著受损,而该脑区此前被认为在AD发病机制中没有实质性参与。